Pregnancy and Infant Outcomes in Women With Multiple Sclerosis Treated With Ocrelizumab.

Vukusic S, Bove R, Dobson R, McElrath T, Oreja-Guevara C, Pietrasanta C, Lin CJ, Ferreira G, Craveiro L, Zecevic D, Pasquarelli N, Hellwig K

Open source

DOI
10.1212/nxi.0000000000200349
Published
2025 Jan
Container
Neurology(R) neuroimmunology & neuroinflammation
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1212/nxi.0000000000200349,
  title = {Pregnancy and Infant Outcomes in Women With Multiple Sclerosis Treated With Ocrelizumab.},
  author = {Vukusic S and Bove R and Dobson R and McElrath T and Oreja-Guevara C and Pietrasanta C and Lin CJ and Ferreira G and Craveiro L and Zecevic D and Pasquarelli N and Hellwig K},
  year = {2025},
  journal = {Neurology(R) neuroimmunology \& neuroinflammation},
  doi = {10.1212/nxi.0000000000200349},
  url = {https://doi.org/10.1212/nxi.0000000000200349}
}

RIS

TY  - JOUR
TI  - Pregnancy and Infant Outcomes in Women With Multiple Sclerosis Treated With Ocrelizumab.
AU  - Vukusic S
AU  - Bove R
AU  - Dobson R
AU  - McElrath T
AU  - Oreja-Guevara C
AU  - Pietrasanta C
AU  - Lin CJ
AU  - Ferreira G
AU  - Craveiro L
AU  - Zecevic D
AU  - Pasquarelli N
AU  - Hellwig K
PY  - 2025
JO  - Neurology(R) neuroimmunology & neuroinflammation
DO  - 10.1212/nxi.0000000000200349
UR  - https://doi.org/10.1212/nxi.0000000000200349
ER  - 

APA

S, V., R, B., R, D., T, M., C, O., C, P., CJ, L., G, F., L, C., D, Z., N, P., & K, H. (2025). Pregnancy and Infant Outcomes in Women With Multiple Sclerosis Treated With Ocrelizumab.. Neurology(R) neuroimmunology & neuroinflammation. https://doi.org/10.1212/nxi.0000000000200349

Source records